ChiCTR2300069870 版本V1.1 版本创建时间2023/06/02 23:21:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300069870 

最近更新日期:

Date of Last Refreshed on:

2023-03-28 14:55:41 

注册时间:

Date of Registration:

2023-03-28 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

阻塞性睡眠呼吸暂停患者远程管理与传统管理两种模式的比较研究

Public title:

A comparative study of remote management and traditional management of patients with obstructive sleep apnea

注册题目简写:

English Acronym:

研究课题的正式科学名称:

阻塞性睡眠呼吸暂停患者远程管理与传统管理两种模式的比较研究

Scientific title:

A comparative study of remote management and traditional management of patients with obstructive sleep apnea

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

裴果 

研究负责人:

欧琼 

Applicant:

Pei Guo 

Study leader:

Ou Qiong 

申请注册联系人电话:

Applicant telephone:

15237366521

研究负责人电话:

Study leader's telephone:

13609717251

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

pg15237366521@163.com

研究负责人电子邮件:

Study leader's E-mail:

ouqiong2776@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市越秀区中山二路106号广东省人民医院

研究负责人通讯地址:

广东省广州市越秀区中山二路106号广东省人民医院

Applicant address:

Guangdong Provincial People's Hospital, 106 Zhongshan Second Road, Yuexiu District, Guangzhou City, Guangdong Province

Study leader's address:

Guangdong Provincial People's Hospital, 106 Zhongshan Second Road, Yuexiu District, Guangzhou City, Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

510080

研究负责人邮政编码:

Study leader's postcode:

510080

申请人所在单位:

广东省人民医院

Applicant's institution:

Guangdong Provincial People's Hospital

研究负责人所在单位:

广东省人民医院

Affiliation of the Leader:

Guangdong Provincial People's Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY-Q-2021-162-02

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广东省人民医院伦理审查委员会

Name of the ethic committee:

Ethics Review Committee of Guangdong Provincial People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2021-08-23 00:00:00

伦理委员会联系人:

姚丽明

Contact Name of the ethic committee:

Yao Liming

伦理委员会联系地址:

广东省广州市越秀区中山二路106号广东省人民医院

Contact Address of the ethic committee:

Guangdong Provincial People's Hospital, 106 Zhongshan Second Road, Yuexiu District, Guangzhou City, Guangdong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

020-83525975

伦理委员会联系人邮箱:

Contact email of the ethic committee:

yaoliming@gdph.org.cn

研究实施负责(组长)单位:

广东省人民医院

Primary sponsor:

Guangdong Provincial People's Hospital

研究实施负责(组长)单位地址:

广东省广州市越秀区中山二路106号广东省人民医院

Primary sponsor's address:

Guangdong Provincial People's Hospital, 106 Zhongshan Second Road, Yuexiu District, Guangzhou City, Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

广州市

Country:

CHINA

Province:

Guangdong Province

City:

Guangzhou City

单位(医院):

广东省人民医院

具体地址:

广东省广州市越秀区中山二路106号广东省人民医院

Institution
hospital:

Guangdong Provincial People's Hospital

Address:

Guangdong Provincial People's Hospital, 106 Zhongshan Second Road, Yuexiu District, Guangzhou City, Guangdong Province

经费或物资来源:

Source(s) of funding:

Non

Target disease:

Obstructive sleep apnea

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

主要目的:比较睡眠呼吸暂停的传统诊疗与远程诊疗模式之间的不同。 次要目的:评价与传统管理模式相比,远程管理模式是否提高了疾病的诊治效率以及PAP治疗依从性,是否可以改善患者症状,节省患者就医成本,比较分析不同OSA表型的患者更适合哪种诊疗模式。  

Objectives of Study:

Objective: To compare the traditional diagnosis and treatment of sleep apnea with remote diagnosis and treatment. Secondary objective: To evaluate whether remote management mode, compared with traditional management mode, can improve the efficiency of diagnosis and treatment of diseases and PAP treatment compliance, improve patients' symptoms and save patients' medical costs, and compare and analyze which diagnosis and treatment mode is more suitable for patients with different OSA phenotypes.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1、年龄18-65岁,男女性别不限;
2、来睡眠中心诊疗、打鼾、怀疑有睡眠呼吸暂停且需要进行便携式睡眠监测的患者;

Inclusion criteria

1. Age 18-65 years old, male and female;
2. Patients who come to the sleep center for treatment, snore, suspected sleep apnea, and need portable sleep monitoring;

排除标准:

1、不配合问卷及随访;
2、中枢性睡眠呼吸暂停、潮式呼吸、肥胖低通气综合征或发作性睡病;
3、曾接受过PAP、手术等OSA治疗或目前需吸氧治疗;
4、6个月内经常出差或工作时间不规律、夜班较多;
5、患有肿瘤、冠心病等器质性疾病或焦虑、抑郁等精神疾病;
6、怀孕或备孕;
7、年龄>60岁或不熟悉网络等人群;
8、研究者认为不适合参加研究。

Exclusion criteria:

1. Do not cooperate with questionnaire and follow-up;
2. Central sleep apnea, tidal respiration, obesity hypopnea syndrome or narcolepsy;
3. Have received OSA therapy such as PAP and surgery or currently need oxygen therapy;
4. Frequent business trips or irregular working hours with more night shifts within 6 months;
5. Patients with organic diseases such as tumors, coronary heart disease or mental diseases such as anxiety and depression;
6. Pregnant or preparing for pregnancy;
7. Age > 60 or unfamiliar with the Internet;
8. The researcher thinks it is not suitable to participate in the study.

研究实施时间:

Study execute time:

From 2021-12-31 00:00:00 To 2023-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-12-31 00:00:00 To 2022-12-31 00:00:00  

干预措施:

Interventions:

组别:

远程管理组

样本量:

63

Group:

Remote management group

Sample size:

干预措施:

远程管理模式

干预措施代码:

Intervention:

Remote management mode

Intervention code:

组别:

传统管理组

样本量:

63

Group:

Traditional management group

Sample size:

干预措施:

传统面对面管理模式

干预措施代码:

Intervention:

Traditional face-to-face management mode

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

广州市 

Country:

CHINA 

Province:

Guangdong 

City:

Guangzhou 

单位(医院):

广东省人民医院 

单位级别:

省级三甲 

Institution
hospital:

Guangdong Provincial People's Hospital

Level of the institution:

Provincial-level top three

测量指标:

Outcomes:

指标中文名:

PAP治疗依从性

指标类型:

主要指标

Outcome:

Compliance with PAP therapy

Type:

Primary indicator

测量时间点:

治疗后1周、1个月、3个月、6个月

测量方法:

从呼吸机下载

Measure time point of outcome:

1 week, 1 month, 3 months, 6 months after treatment

Measure method:

Download it from the ventilator

指标中文名:

医疗成本效益

指标类型:

主要指标

Outcome:

Medical cost-effectiveness

Type:

Primary indicator

测量时间点:

每次就诊

测量方法:

Measure time point of outcome:

Every visit

Measure method:

指标中文名:

症状量表指标

指标类型:

次要指标

Outcome:

Symptom scale indicator

Type:

Secondary indicator

测量时间点:

首次就诊和末次随访

测量方法:

量表评估

Measure time point of outcome:

First visit and last follow-up

Measure method:

Scale evaluation

指标中文名:

睡眠呼吸指标

指标类型:

次要指标

Outcome:

Sleep respiratory index

Type:

Secondary indicator

测量时间点:

诊断后

测量方法:

睡眠监测

Measure time point of outcome:

post-diagnosis

Measure method:

Sleep monitoring

指标中文名:

HST佩戴失败率

指标类型:

次要指标

Outcome:

HST wearing failure rate

Type:

Secondary indicator

测量时间点:

诊断后

测量方法:

Measure time point of outcome:

post-diagnosis

Measure method:

指标中文名:

医生干预次数

指标类型:

次要指标

Outcome:

Number of physician interventions

Type:

Secondary indicator

测量时间点:

每次就诊

测量方法:

人工记录

Measure time point of outcome:

Every visit

Measure method:

Manual recording

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

No

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

按照初步计算的样本观察例数126例,给出包含1-126(包括脱落病例)的随机数字表,项目组的每个主要研究者按顺序分配病例编号,每个病例编号已随机有对应的A或B组别,A组为传统管理模式组,B组为远程管理模式组。

Randomization Procedure (please state who generates the random number sequence and by what method):

According to the preliminary calculation of 126 sample observation cases, A random number table containing 1-126 (including shedding cases) was given. Each main researcher of the project team assigned case numbers in order, and each case number was randomly assigned to group A or Group B, group A was th

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

http://www.medresman.org/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://www.medresman.org/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表采集,并录入电子表格

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Collect and input the medical record form into the electronic form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2023-03-28 14:55:29